Search results for "Side effects"
Comprehensive study finds vaccines remarkably safe
The most common safety issue that resulted in label changes for vaccines was a restriction on the population to be vaccinated, such as pregnant or immunocompromised patients.
https://immattersacp.org/weekly/archives/2020/07/28/4.htm
28 Jul 2020
Balancing benefits and harms of pain meds in older adults
Pain guidelines issued by medical societies call for nondrug therapies and exercise as primary recommendations for chronic pain.
https://immattersacp.org/archives/2023/07/balancing-benefits-and-harms-of-pain-meds-in-older-adults.htm
1 Jul 2023
Anti-inflammatory agents may effectively, safely curb major depressive symptoms, study finds
A pooled data analysis looked at depression treatment trials that compared NSAIDs, omega-3 fatty acids, cytokine inhibitors, statins, steroids, minocycline, modafinil, or N-acetylcysteine to placebo.
https://immattersacp.org/weekly/archives/2019/11/05/4.htm
5 Nov 2019
Monkeypox: 5 key points
An expert panel convened by ACP and Annals of Internal Medicine provided five key takeaways about diagnosing and managing monkeypox.
https://immattersacp.org/archives/2022/11/monkeypox-5-key-points.htm
1 Nov 2022
MKSAP Quiz: Follow-up for Barrett esophagus
A 65-year-old man is evaluated with upper endoscopy in follow-up for Barrett esophagus. He has had heartburn for more than 15 years, but his symptoms have been well controlled with daily omeprazole. Biopsies confirm evidence of Barrett esophagus with low-grade dysplasia. What is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2020/10/06/3.htm
6 Oct 2020
A living guideline for depression treatment
ACP recommends choosing between a second-generation antidepressant or cognitive behavioral therapy for adults in the acute phase of moderate to severe major depressive disorder.
https://immattersacp.org/archives/2023/06/a-living-guideline-for-depression-treatment.htm
1 Jun 2023
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
More tools available for treating IBS
Irritable bowel syndrome (IBS) is not a new disorder, but physicians' understanding of its pathophysiology and treatment has greatly progressed over the years.
https://immattersacp.org/archives/2023/01/more-tools-available-for-treating-ibs.htm
1 Jan 2023
MKSAP Quiz: 6 months of exertional dyspnea
A 46-year-old man is evaluated for 6 months of exertional dyspnea, fatigue, and ankle edema. Recently he experienced near-syncope walking up two flights of stairs. He has no other medical problems and takes no medications. Following a physical exam, transthoracic echocardiogram, and other tests, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2020/06/09/3.htm
9 Jun 2020
OTC birth control pill, naloxone gain approval
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023